Cargando…

Vascular complications with a plug‐based vascular closure device after transcatheter aortic valve replacement: Predictors and bail‐outs

BACKGROUND: The MANTA vascular closure device (VCD) is dedicated to large bore access closure and associated with favorable results in selected study populations. Anatomical predictors for access site complications are lacking. AIM: To evaluate MANTA in a real‐world population and identify predictor...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Wiechen, Maarten P., Kroon, Herbert, Hokken, Thijmen W., Ooms, Joris F., de Ronde‐Tillmans, Marjo J., Daemen, Joost, de Jaegere, Peter P., Van Mieghem, Nicolas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Valvular and Structural Heart Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292646/ https://www.ncbi.nlm.nih.gov/pubmed/33533544 http://dx.doi.org/10.1002/ccd.29506

Ejemplares similares

Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program
por: Hokken, Thijmen W., et al.
Publicado: (2021)

Dedicated plug based closure for large bore access –The MARVEL prospective registry
por: Kroon, Herbert G., et al.
Publicado: (2020)

Changing haemodynamic status of patients referred for transcatheter aortic valve intervention during the COVID-19 pandemic
por: Ooms, Joris F., et al.
Publicado: (2023)

Publisher Correction to: Changing haemodynamic status of patients referred for transcatheter aortic valve intervention during the COVID-19 pandemic
por: Ooms, Joris F., et al.
Publicado: (2023)

Transcatheter Repair and Replacement Technologies for Mitral Regurgitation: a European Perspective
por: Ooms, Joris F., et al.
Publicado: (2021)

Data on plug-based large-bore arteriotomy vascular closure device related access complications
por: Nuis, Rutger-Jan, et al.
Publicado: (2021)

Long term follow‐up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications
por: Maurina, Matteo, et al.
Publicado: (2022)

Large-bore Vascular Closure: New Devices and Techniques
por: van Wiechen, Maarten P, et al.
Publicado: (2019)

The Impact of the COVID-19 Pandemic on the Clinical Status of Patients Referred for TAVR
por: Ooms, Joris F., et al.
Publicado: (2022)

Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study
por: Van Mieghem, Nicolas M., et al.
Publicado: (2021)

Percutaneous decannulation of extracorporeal membrane oxygenation using a plug‐based closure device
por: Dalén, Magnus, et al.
Publicado: (2022)

TCT-422 The Impact of the COVID-19 Pandemic on the Clinical Status of Patients Referred for TAVR
por: Ooms, Joris, et al.
Publicado: (2021)

Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome
por: Meijerink, Frank, et al.
Publicado: (2021)

The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study
por: Dautzenberg, Lauren, et al.
Publicado: (2022)

Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
por: Goldsweig, Andrew M., et al.
Publicado: (2022)

Impact of frailty on health-related quality of life 1 year after transcatheter aortic valve implantation
por: Goudzwaard, Jeannette A, et al.
Publicado: (2020)

Multidimensional Prognostic Index and Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Implantation: Survival of the Fittest
por: Goudzwaard, Jeannette A., et al.
Publicado: (2021)

Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement
por: Isogai, Toshiaki, et al.
Publicado: (2022)

Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
por: Liu, Xianbao, et al.
Publicado: (2021)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Transcatheter aortic valve implantation with the novel‐generation Navitor device: Procedural and early outcomes
por: Corcione, Nicola, et al.
Publicado: (2022)

Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation
por: Asami, Masahiko, et al.
Publicado: (2022)

Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex
por: Yong, Celina M., et al.
Publicado: (2022)

Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair
por: Miller, Matthew S., et al.
Publicado: (2022)

Changes in demographics, treatment and outcomes in a consecutive cohort who underwent transcatheter aortic valve implantation between 2005 and 2020
por: De Ronde-Tillmans, M. J. A. G., et al.
Publicado: (2022)

Clinical risk model for predicting 1‐year mortality after transcatheter aortic valve replacement
por: Yamamoto, Masanori, et al.
Publicado: (2020)

Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

SAPIEN 3 transcatheter heart valve in patients with borderline annulus: “stretched better than bigger?”
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Transcatheter mitral valve repair in proportionate and disproportionate functional mitral regurgitation—insights from a small cohort study
por: Ooms, J. F., et al.
Publicado: (2021)

Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI‐NHR risk model
por: Al‐Farra, Hatem, et al.
Publicado: (2022)

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve
por: Liu, Xianbao, et al.
Publicado: (2018)

Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry
por: Moriyama, Noriaki, et al.
Publicado: (2020)

Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis
por: Kooistra, Nynke H., et al.
Publicado: (2020)

A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)

Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study
por: Blackman, Daniel J., et al.
Publicado: (2019)

Conceptual model for early health technology assessment of current and novel heart valve interventions
por: Huygens, Simone A, et al.
Publicado: (2016)

Transcatheter mitral valve repair: an overview of current and future devices
por: De Backer, Ole, et al.
Publicado: (2021)

Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database
por: Ullah, Waqas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oso4qtfjbhmhpq43jqo7k6u7hn